Margossian Renee
Department of Cardiology, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA.
Expert Rev Cardiovasc Ther. 2008 Feb;6(2):187-97. doi: 10.1586/14779072.6.2.187.
The spectrum of causes of pediatric heart failure is broad and differs significantly from that seen in most adult patients. Left-to-right shunts and outflow obstruction lesions are responsible for a large number of pediatric cases of heart failure. Most of these are now treated successfully with surgery or catheter intervention. Medical therapy is the mainstay of care for myocardial disorders with diuretics, angiotensin-converting enzyme inhibitors, beta-blockade and cardiac glycosides. There are few prospective trials of these agents in a pediatric population, but extrapolated data support their use in children. In addition to medical therapy, interventions such as automatic implantable cardioverter defibrillators and resynchronization therapy have become increasingly common in pediatric heart disease, as well as in adult patients with congenital heart disease.
小儿心力衰竭的病因范围广泛,与大多数成年患者有显著差异。左向右分流和流出道梗阻性病变是导致大量小儿心力衰竭病例的原因。目前,其中大多数通过手术或导管介入治疗已取得成功。药物治疗是心肌疾病治疗的主要手段,包括利尿剂、血管紧张素转换酶抑制剂、β受体阻滞剂和强心苷。针对这些药物在儿科人群中的前瞻性试验较少,但外推数据支持在儿童中使用。除药物治疗外,自动植入式心律转复除颤器和心脏再同步治疗等干预措施在小儿心脏病以及患有先天性心脏病的成年患者中越来越普遍。